Streetbeat News

Stock Prices

ANF

Abercrombie & Fitch shares rise as JP Morgan maintains an Overweight rating and slightly increases the price target from $194 to $195. The stock also benefits from positive sentiment following a tentative agreement in the dockworker strike.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 7:04 pm

PEPEUSD

Pepe's cryptocurrency price increased by 9.95% in the last 24 hours, despite a 12% loss over the past week. The trading volume decreased by 26% while the circulating supply increased slightly. Pepe's market cap is ranked #31 at $3.96 billion.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:02 pm

RGLD

In the past three months, six analysts have provided ratings for Royal Gold (NASDAQ:RGLD), with a mix of somewhat bullish and indifferent sentiments. The average 12-month price target has increased by 5.11% to $161.17. Analysts have raised their price targets, reflecting a positive outlook on Royal Gold's financial performance, including strong revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:02 pm

SCHW

Analysts have mixed views on Charles Schwab (NYSE:SCHW) with recent ratings showing a blend of bullish and bearish sentiments. The average 12-month price target has decreased by 5.41% to $74.78. Analysts have adjusted their ratings and price targets in response to market dynamics, with several lowering their targets. Despite challenges in revenue growth and returns, Schwab maintains a strong market position with a large market cap and efficient cost management.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:01 pm

COHR

Coherent (NYSE:COHR) has received diverse evaluations from 15 analysts over the past three months, with a majority being bullish. The average 12-month price target has increased by 20.19% to $82.93. Analysts have raised their ratings and price targets, reflecting positive sentiment. Coherent's financial performance shows strong revenue growth and market position, but also highlights financial risks due to high debt levels.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:01 pm

REGN

Over the past three months, 24 analysts have evaluated Regeneron Pharmaceuticals (NASDAQ:REGN), with a majority being somewhat bullish. The average 12-month price target has increased by 3.71% to $1194.29. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Regeneron has shown strong financial performance with a notable net margin and ROE, despite lagging revenue growth compared to peers.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:00 pm

UNM

Unum Group (NYSE: UNM) has seen a 1.18% increase in its stock price, now trading at $60.00. Over the past month, the stock rose by 13.13%, and by 22.89% over the past year. Despite this growth, its P/E ratio of 8.71 is lower than the insurance industry average of 19.12, suggesting potential undervaluation or weak growth prospects.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:00 pm

MPC

Analysts have mixed views on Marathon Petroleum (NYSE:MPC) with recent ratings showing a decrease in average price targets. Despite positive financial metrics, concerns about debt management persist.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:00 pm

ETHUSD

Ethereum's price has increased by 3.61% in the last 24 hours, reaching $2,428.50, despite a 11% loss over the past week. Trading volume has decreased by 13% while circulating supply increased by 0.2%. Ethereum's market cap is ranked #2 at $292.22 billion.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:00 pm